Daxxify and Jeuveau occupy opposite ends of the neuromodulator spectrum: Daxxify is FDA-cleared for up to 6 months of effect, while Jeuveau typically lasts 3–4 months, matching standard Botox and Dysport duration. The real differentiation lies in per-treatment cost, patient retention, and how each fits into your revenue model.
Injectables
Daxxify vs Jeuveau: Duration, Cost, and Clinical Positioning
How the extended-duration toxin and the budget neuromodulator stack up on longevity, per-treatment economics, and market positioning.
